nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—ABCC3—ABC-family proteins mediated transport—PEX19—glaucoma	0.00546	0.105	CbGpPWpGaD
Gadoxetate—ABCC4—ABC-family proteins mediated transport—PEX19—glaucoma	0.00513	0.0991	CbGpPWpGaD
Gadoxetate—ABCC2—ABC-family proteins mediated transport—PEX19—glaucoma	0.00433	0.0835	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—SIX6—glaucoma	0.00206	0.0398	CbGpPWpGaD
Gadoxetate—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.00131	0.0252	CbGpPWpGaD
Gadoxetate—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.00104	0.02	CbGpPWpGaD
Gadoxetate—ABCC3—Fluoropyrimidine Activity—MTHFR—glaucoma	0.000946	0.0182	CbGpPWpGaD
Gadoxetate—Fatigue—Brimonidine—glaucoma	0.000934	0.000985	CcSEcCtD
Gadoxetate—Anorexia—Pilocarpine—glaucoma	0.000932	0.000983	CcSEcCtD
Gadoxetate—Feeling abnormal—Acetazolamide—glaucoma	0.00093	0.000981	CcSEcCtD
Gadoxetate—Hypersensitivity—Apraclonidine—glaucoma	0.00093	0.00098	CcSEcCtD
Gadoxetate—Paraesthesia—Dorzolamide—glaucoma	0.000929	0.00098	CcSEcCtD
Gadoxetate—Dyspnoea—Dorzolamide—glaucoma	0.000922	0.000973	CcSEcCtD
Gadoxetate—Dyspnoea—Travoprost—glaucoma	0.000918	0.000969	CcSEcCtD
Gadoxetate—Hypotension—Pilocarpine—glaucoma	0.000913	0.000963	CcSEcCtD
Gadoxetate—Paraesthesia—Brinzolamide—glaucoma	0.000913	0.000963	CcSEcCtD
Gadoxetate—Dyspnoea—Brinzolamide—glaucoma	0.000907	0.000956	CcSEcCtD
Gadoxetate—Asthenia—Apraclonidine—glaucoma	0.000905	0.000955	CcSEcCtD
Gadoxetate—Vision blurred—Clonidine—glaucoma	0.000901	0.000951	CcSEcCtD
Gadoxetate—Decreased appetite—Dorzolamide—glaucoma	0.000899	0.000948	CcSEcCtD
Gadoxetate—Urticaria—Acetazolamide—glaucoma	0.000897	0.000946	CcSEcCtD
Gadoxetate—Tremor—Clonidine—glaucoma	0.000896	0.000945	CcSEcCtD
Gadoxetate—Pruritus—Apraclonidine—glaucoma	0.000893	0.000941	CcSEcCtD
Gadoxetate—Body temperature increased—Acetazolamide—glaucoma	0.000892	0.000941	CcSEcCtD
Gadoxetate—Fatigue—Dorzolamide—glaucoma	0.000892	0.000941	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Travoprost—glaucoma	0.000889	0.000938	CcSEcCtD
Gadoxetate—ABCC4—Fluoropyrimidine Activity—MTHFR—glaucoma	0.000889	0.0172	CbGpPWpGaD
Gadoxetate—Fatigue—Travoprost—glaucoma	0.000888	0.000937	CcSEcCtD
Gadoxetate—Cardiac disorder—Betaxolol—glaucoma	0.000888	0.000936	CcSEcCtD
Gadoxetate—Flushing—Betaxolol—glaucoma	0.000888	0.000936	CcSEcCtD
Gadoxetate—Ill-defined disorder—Clonidine—glaucoma	0.000887	0.000936	CcSEcCtD
Gadoxetate—Decreased appetite—Brinzolamide—glaucoma	0.000884	0.000932	CcSEcCtD
Gadoxetate—Constipation—Travoprost—glaucoma	0.000881	0.000929	CcSEcCtD
Gadoxetate—Agitation—Clonidine—glaucoma	0.000879	0.000927	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000878	0.000926	CcSEcCtD
Gadoxetate—Paraesthesia—Pilocarpine—glaucoma	0.000878	0.000926	CcSEcCtD
Gadoxetate—Asthenia—Bimatoprost—glaucoma	0.000878	0.000926	CcSEcCtD
Gadoxetate—Fatigue—Brinzolamide—glaucoma	0.000877	0.000925	CcSEcCtD
Gadoxetate—Dyspnoea—Pilocarpine—glaucoma	0.000872	0.000919	CcSEcCtD
Gadoxetate—Angiopathy—Betaxolol—glaucoma	0.000868	0.000915	CcSEcCtD
Gadoxetate—Pruritus—Bimatoprost—glaucoma	0.000866	0.000913	CcSEcCtD
Gadoxetate—Immune system disorder—Betaxolol—glaucoma	0.000864	0.000911	CcSEcCtD
Gadoxetate—Diarrhoea—Apraclonidine—glaucoma	0.000863	0.000911	CcSEcCtD
Gadoxetate—Malaise—Clonidine—glaucoma	0.000863	0.00091	CcSEcCtD
Gadoxetate—Mediastinal disorder—Betaxolol—glaucoma	0.000862	0.000909	CcSEcCtD
Gadoxetate—Chills—Betaxolol—glaucoma	0.000858	0.000905	CcSEcCtD
Gadoxetate—Syncope—Clonidine—glaucoma	0.000858	0.000905	CcSEcCtD
Gadoxetate—Arrhythmia—Betaxolol—glaucoma	0.000855	0.000901	CcSEcCtD
Gadoxetate—Feeling abnormal—Dorzolamide—glaucoma	0.000853	0.000899	CcSEcCtD
Gadoxetate—Decreased appetite—Pilocarpine—glaucoma	0.00085	0.000896	CcSEcCtD
Gadoxetate—Feeling abnormal—Travoprost—glaucoma	0.000849	0.000895	CcSEcCtD
Gadoxetate—Conjunctivitis—Timolol—glaucoma	0.000846	0.000892	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Dorzolamide—glaucoma	0.000846	0.000892	CcSEcCtD
Gadoxetate—Palpitations—Clonidine—glaucoma	0.000845	0.000891	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000844	0.00089	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Travoprost—glaucoma	0.000842	0.000888	CcSEcCtD
Gadoxetate—Loss of consciousness—Clonidine—glaucoma	0.000841	0.000887	CcSEcCtD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.00084	0.0162	CbGpPWpGaD
Gadoxetate—Feeling abnormal—Brinzolamide—glaucoma	0.000838	0.000884	CcSEcCtD
Gadoxetate—Constipation—Pilocarpine—glaucoma	0.000836	0.000882	CcSEcCtD
Gadoxetate—Cough—Clonidine—glaucoma	0.000835	0.00088	CcSEcCtD
Gadoxetate—Dizziness—Apraclonidine—glaucoma	0.000834	0.00088	CcSEcCtD
Gadoxetate—Urticaria—Dorzolamide—glaucoma	0.000822	0.000867	CcSEcCtD
Gadoxetate—Abdominal pain—Dorzolamide—glaucoma	0.000818	0.000863	CcSEcCtD
Gadoxetate—Body temperature increased—Dorzolamide—glaucoma	0.000818	0.000863	CcSEcCtD
Gadoxetate—Dysgeusia—Betaxolol—glaucoma	0.000815	0.00086	CcSEcCtD
Gadoxetate—Chest pain—Clonidine—glaucoma	0.000814	0.000859	CcSEcCtD
Gadoxetate—Abdominal pain—Travoprost—glaucoma	0.000814	0.000859	CcSEcCtD
Gadoxetate—Anxiety—Clonidine—glaucoma	0.000812	0.000856	CcSEcCtD
Gadoxetate—Asthenia—Acetazolamide—glaucoma	0.00081	0.000854	CcSEcCtD
Gadoxetate—Dizziness—Bimatoprost—glaucoma	0.000809	0.000853	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000809	0.000853	CcSEcCtD
Gadoxetate—Urticaria—Brinzolamide—glaucoma	0.000808	0.000852	CcSEcCtD
Gadoxetate—Feeling abnormal—Pilocarpine—glaucoma	0.000806	0.00085	CcSEcCtD
Gadoxetate—Discomfort—Clonidine—glaucoma	0.000805	0.000849	CcSEcCtD
Gadoxetate—ABCC3—NRF2 pathway—SLC6A13—glaucoma	0.000803	0.0155	CbGpPWpGaD
Gadoxetate—Vomiting—Apraclonidine—glaucoma	0.000802	0.000846	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Pilocarpine—glaucoma	0.000799	0.000843	CcSEcCtD
Gadoxetate—Hypersensitivity—Brimonidine—glaucoma	0.000798	0.000842	CcSEcCtD
Gadoxetate—Dry mouth—Clonidine—glaucoma	0.000796	0.00084	CcSEcCtD
Gadoxetate—Dermatitis—Apraclonidine—glaucoma	0.000795	0.000838	CcSEcCtD
Gadoxetate—Headache—Apraclonidine—glaucoma	0.00079	0.000834	CcSEcCtD
Gadoxetate—Vision blurred—Betaxolol—glaucoma	0.000785	0.000828	CcSEcCtD
Gadoxetate—Rhinitis—Timolol—glaucoma	0.000783	0.000826	CcSEcCtD
Gadoxetate—Oedema—Clonidine—glaucoma	0.000781	0.000823	CcSEcCtD
Gadoxetate—Tremor—Betaxolol—glaucoma	0.00078	0.000823	CcSEcCtD
Gadoxetate—Asthenia—Brimonidine—glaucoma	0.000777	0.00082	CcSEcCtD
Gadoxetate—Infection—Clonidine—glaucoma	0.000776	0.000818	CcSEcCtD
Gadoxetate—Body temperature increased—Pilocarpine—glaucoma	0.000773	0.000815	CcSEcCtD
Gadoxetate—Abdominal pain—Pilocarpine—glaucoma	0.000773	0.000815	CcSEcCtD
Gadoxetate—Ill-defined disorder—Betaxolol—glaucoma	0.000773	0.000815	CcSEcCtD
Gadoxetate—Diarrhoea—Acetazolamide—glaucoma	0.000772	0.000814	CcSEcCtD
Gadoxetate—Rash—Bimatoprost—glaucoma	0.000771	0.000814	CcSEcCtD
Gadoxetate—Dermatitis—Bimatoprost—glaucoma	0.000771	0.000813	CcSEcCtD
Gadoxetate—Shock—Clonidine—glaucoma	0.000768	0.00081	CcSEcCtD
Gadoxetate—Connective tissue disorder—Timolol—glaucoma	0.000768	0.00081	CcSEcCtD
Gadoxetate—Pruritus—Brimonidine—glaucoma	0.000766	0.000808	CcSEcCtD
Gadoxetate—Headache—Bimatoprost—glaucoma	0.000766	0.000808	CcSEcCtD
Gadoxetate—Nervous system disorder—Clonidine—glaucoma	0.000766	0.000807	CcSEcCtD
Gadoxetate—Hypersensitivity—Dorzolamide—glaucoma	0.000762	0.000804	CcSEcCtD
Gadoxetate—Tachycardia—Clonidine—glaucoma	0.000762	0.000804	CcSEcCtD
Gadoxetate—Hypersensitivity—Travoprost—glaucoma	0.000759	0.0008	CcSEcCtD
Gadoxetate—Skin disorder—Clonidine—glaucoma	0.000758	0.0008	CcSEcCtD
Gadoxetate—ABCC4—NRF2 pathway—SLC6A13—glaucoma	0.000755	0.0146	CbGpPWpGaD
Gadoxetate—Hyperhidrosis—Clonidine—glaucoma	0.000755	0.000796	CcSEcCtD
Gadoxetate—Malaise—Betaxolol—glaucoma	0.000751	0.000792	CcSEcCtD
Gadoxetate—Nausea—Apraclonidine—glaucoma	0.000749	0.00079	CcSEcCtD
Gadoxetate—Hypersensitivity—Brinzolamide—glaucoma	0.000749	0.00079	CcSEcCtD
Gadoxetate—Vertigo—Betaxolol—glaucoma	0.000748	0.000789	CcSEcCtD
Gadoxetate—Syncope—Betaxolol—glaucoma	0.000747	0.000788	CcSEcCtD
Gadoxetate—Dizziness—Acetazolamide—glaucoma	0.000746	0.000787	CcSEcCtD
Gadoxetate—Anorexia—Clonidine—glaucoma	0.000744	0.000785	CcSEcCtD
Gadoxetate—Asthenia—Dorzolamide—glaucoma	0.000742	0.000783	CcSEcCtD
Gadoxetate—Asthenia—Travoprost—glaucoma	0.000739	0.000779	CcSEcCtD
Gadoxetate—Palpitations—Betaxolol—glaucoma	0.000736	0.000776	CcSEcCtD
Gadoxetate—Pruritus—Dorzolamide—glaucoma	0.000732	0.000772	CcSEcCtD
Gadoxetate—Loss of consciousness—Betaxolol—glaucoma	0.000732	0.000772	CcSEcCtD
Gadoxetate—Asthenia—Brinzolamide—glaucoma	0.00073	0.00077	CcSEcCtD
Gadoxetate—Hypotension—Clonidine—glaucoma	0.000729	0.000769	CcSEcCtD
Gadoxetate—Pruritus—Travoprost—glaucoma	0.000729	0.000769	CcSEcCtD
Gadoxetate—ABCC4—Platelet degranulation—TGFB2—glaucoma	0.000729	0.0141	CbGpPWpGaD
Gadoxetate—Cough—Betaxolol—glaucoma	0.000727	0.000766	CcSEcCtD
Gadoxetate—Nausea—Bimatoprost—glaucoma	0.000727	0.000766	CcSEcCtD
Gadoxetate—Cardiac disorder—Timolol—glaucoma	0.000725	0.000765	CcSEcCtD
Gadoxetate—Hypersensitivity—Pilocarpine—glaucoma	0.00072	0.00076	CcSEcCtD
Gadoxetate—Pruritus—Brinzolamide—glaucoma	0.00072	0.000759	CcSEcCtD
Gadoxetate—Vomiting—Acetazolamide—glaucoma	0.000718	0.000757	CcSEcCtD
Gadoxetate—Dizziness—Brimonidine—glaucoma	0.000716	0.000755	CcSEcCtD
Gadoxetate—Angiopathy—Timolol—glaucoma	0.000709	0.000748	CcSEcCtD
Gadoxetate—Chest pain—Betaxolol—glaucoma	0.000709	0.000748	CcSEcCtD
Gadoxetate—Diarrhoea—Dorzolamide—glaucoma	0.000708	0.000747	CcSEcCtD
Gadoxetate—Headache—Acetazolamide—glaucoma	0.000707	0.000746	CcSEcCtD
Gadoxetate—Anxiety—Betaxolol—glaucoma	0.000707	0.000745	CcSEcCtD
Gadoxetate—Immune system disorder—Timolol—glaucoma	0.000706	0.000744	CcSEcCtD
Gadoxetate—Diarrhoea—Travoprost—glaucoma	0.000705	0.000743	CcSEcCtD
Gadoxetate—Mediastinal disorder—Timolol—glaucoma	0.000704	0.000743	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000704	0.000743	CcSEcCtD
Gadoxetate—Asthenia—Pilocarpine—glaucoma	0.000701	0.00074	CcSEcCtD
Gadoxetate—Paraesthesia—Clonidine—glaucoma	0.000701	0.000739	CcSEcCtD
Gadoxetate—Discomfort—Betaxolol—glaucoma	0.0007	0.000739	CcSEcCtD
Gadoxetate—Arrhythmia—Timolol—glaucoma	0.000698	0.000736	CcSEcCtD
Gadoxetate—Dyspnoea—Clonidine—glaucoma	0.000696	0.000734	CcSEcCtD
Gadoxetate—Diarrhoea—Brinzolamide—glaucoma	0.000696	0.000734	CcSEcCtD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB2—glaucoma	0.000694	0.0134	CbGpPWpGaD
Gadoxetate—Dry mouth—Betaxolol—glaucoma	0.000693	0.000731	CcSEcCtD
Gadoxetate—Pruritus—Pilocarpine—glaucoma	0.000692	0.000729	CcSEcCtD
Gadoxetate—Dizziness—Dorzolamide—glaucoma	0.000684	0.000721	CcSEcCtD
Gadoxetate—Rash—Brimonidine—glaucoma	0.000683	0.00072	CcSEcCtD
Gadoxetate—Dermatitis—Brimonidine—glaucoma	0.000682	0.00072	CcSEcCtD
Gadoxetate—Dizziness—Travoprost—glaucoma	0.000681	0.000718	CcSEcCtD
Gadoxetate—Oedema—Betaxolol—glaucoma	0.00068	0.000717	CcSEcCtD
Gadoxetate—Headache—Brimonidine—glaucoma	0.000679	0.000716	CcSEcCtD
Gadoxetate—Decreased appetite—Clonidine—glaucoma	0.000679	0.000716	CcSEcCtD
Gadoxetate—Infection—Betaxolol—glaucoma	0.000675	0.000712	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Clonidine—glaucoma	0.000674	0.000711	CcSEcCtD
Gadoxetate—Fatigue—Clonidine—glaucoma	0.000673	0.00071	CcSEcCtD
Gadoxetate—Dizziness—Brinzolamide—glaucoma	0.000673	0.000709	CcSEcCtD
Gadoxetate—Nausea—Acetazolamide—glaucoma	0.00067	0.000707	CcSEcCtD
Gadoxetate—Diarrhoea—Pilocarpine—glaucoma	0.000669	0.000705	CcSEcCtD
Gadoxetate—Shock—Betaxolol—glaucoma	0.000669	0.000705	CcSEcCtD
Gadoxetate—Constipation—Clonidine—glaucoma	0.000668	0.000704	CcSEcCtD
Gadoxetate—Nervous system disorder—Betaxolol—glaucoma	0.000666	0.000703	CcSEcCtD
Gadoxetate—Dysgeusia—Timolol—glaucoma	0.000666	0.000703	CcSEcCtD
Gadoxetate—Tachycardia—Betaxolol—glaucoma	0.000663	0.0007	CcSEcCtD
Gadoxetate—Skin disorder—Betaxolol—glaucoma	0.00066	0.000696	CcSEcCtD
Gadoxetate—ABCC3—NRF2 pathway—TXN—glaucoma	0.000659	0.0127	CbGpPWpGaD
Gadoxetate—Vomiting—Dorzolamide—glaucoma	0.000658	0.000694	CcSEcCtD
Gadoxetate—Hyperhidrosis—Betaxolol—glaucoma	0.000657	0.000693	CcSEcCtD
Gadoxetate—Rash—Dorzolamide—glaucoma	0.000652	0.000688	CcSEcCtD
Gadoxetate—Dermatitis—Dorzolamide—glaucoma	0.000652	0.000687	CcSEcCtD
Gadoxetate—Rash—Travoprost—glaucoma	0.000649	0.000685	CcSEcCtD
Gadoxetate—Dermatitis—Travoprost—glaucoma	0.000649	0.000684	CcSEcCtD
Gadoxetate—Headache—Dorzolamide—glaucoma	0.000648	0.000684	CcSEcCtD
Gadoxetate—Anorexia—Betaxolol—glaucoma	0.000648	0.000683	CcSEcCtD
Gadoxetate—Vomiting—Brinzolamide—glaucoma	0.000647	0.000682	CcSEcCtD
Gadoxetate—Dizziness—Pilocarpine—glaucoma	0.000646	0.000682	CcSEcCtD
Gadoxetate—Headache—Travoprost—glaucoma	0.000645	0.000681	CcSEcCtD
Gadoxetate—Nausea—Brimonidine—glaucoma	0.000643	0.000679	CcSEcCtD
Gadoxetate—Feeling abnormal—Clonidine—glaucoma	0.000643	0.000678	CcSEcCtD
Gadoxetate—Rash—Brinzolamide—glaucoma	0.000641	0.000676	CcSEcCtD
Gadoxetate—Vision blurred—Timolol—glaucoma	0.000641	0.000676	CcSEcCtD
Gadoxetate—Dermatitis—Brinzolamide—glaucoma	0.000641	0.000676	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Clonidine—glaucoma	0.000638	0.000673	CcSEcCtD
Gadoxetate—Headache—Brinzolamide—glaucoma	0.000637	0.000672	CcSEcCtD
Gadoxetate—ABCC2—NRF2 pathway—SLC6A13—glaucoma	0.000637	0.0123	CbGpPWpGaD
Gadoxetate—Hypotension—Betaxolol—glaucoma	0.000635	0.00067	CcSEcCtD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—PEX19—glaucoma	0.000632	0.0122	CbGpPWpGaD
Gadoxetate—Vomiting—Pilocarpine—glaucoma	0.000622	0.000656	CcSEcCtD
Gadoxetate—Urticaria—Clonidine—glaucoma	0.00062	0.000654	CcSEcCtD
Gadoxetate—ABCC4—NRF2 pathway—TXN—glaucoma	0.00062	0.012	CbGpPWpGaD
Gadoxetate—Abdominal pain—Clonidine—glaucoma	0.000617	0.000651	CcSEcCtD
Gadoxetate—Body temperature increased—Clonidine—glaucoma	0.000617	0.000651	CcSEcCtD
Gadoxetate—Rash—Pilocarpine—glaucoma	0.000616	0.00065	CcSEcCtD
Gadoxetate—Dermatitis—Pilocarpine—glaucoma	0.000616	0.000649	CcSEcCtD
Gadoxetate—Nausea—Dorzolamide—glaucoma	0.000614	0.000648	CcSEcCtD
Gadoxetate—Headache—Pilocarpine—glaucoma	0.000612	0.000646	CcSEcCtD
Gadoxetate—Nausea—Travoprost—glaucoma	0.000612	0.000645	CcSEcCtD
Gadoxetate—Vertigo—Timolol—glaucoma	0.000611	0.000645	CcSEcCtD
Gadoxetate—Paraesthesia—Betaxolol—glaucoma	0.00061	0.000644	CcSEcCtD
Gadoxetate—Syncope—Timolol—glaucoma	0.00061	0.000643	CcSEcCtD
Gadoxetate—Dyspnoea—Betaxolol—glaucoma	0.000606	0.000639	CcSEcCtD
Gadoxetate—Nausea—Brinzolamide—glaucoma	0.000604	0.000637	CcSEcCtD
Gadoxetate—Palpitations—Timolol—glaucoma	0.000601	0.000634	CcSEcCtD
Gadoxetate—Loss of consciousness—Timolol—glaucoma	0.000598	0.000631	CcSEcCtD
Gadoxetate—Cough—Timolol—glaucoma	0.000594	0.000626	CcSEcCtD
Gadoxetate—Decreased appetite—Betaxolol—glaucoma	0.000591	0.000623	CcSEcCtD
Gadoxetate—ABCC3—NRF2 pathway—SLC6A1—glaucoma	0.000588	0.0113	CbGpPWpGaD
Gadoxetate—Gastrointestinal disorder—Betaxolol—glaucoma	0.000587	0.000619	CcSEcCtD
Gadoxetate—Fatigue—Betaxolol—glaucoma	0.000586	0.000618	CcSEcCtD
Gadoxetate—Constipation—Betaxolol—glaucoma	0.000581	0.000613	CcSEcCtD
Gadoxetate—Nausea—Pilocarpine—glaucoma	0.000581	0.000612	CcSEcCtD
Gadoxetate—Chest pain—Timolol—glaucoma	0.000579	0.000611	CcSEcCtD
Gadoxetate—Anxiety—Timolol—glaucoma	0.000577	0.000609	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000575	0.000607	CcSEcCtD
Gadoxetate—Hypersensitivity—Clonidine—glaucoma	0.000575	0.000607	CcSEcCtD
Gadoxetate—Discomfort—Timolol—glaucoma	0.000572	0.000604	CcSEcCtD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—PEX19—glaucoma	0.00057	0.011	CbGpPWpGaD
Gadoxetate—Dry mouth—Timolol—glaucoma	0.000566	0.000597	CcSEcCtD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000565	0.0109	CbGpPWpGaD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000561	0.0108	CbGpPWpGaD
Gadoxetate—Asthenia—Clonidine—glaucoma	0.00056	0.000591	CcSEcCtD
Gadoxetate—Feeling abnormal—Betaxolol—glaucoma	0.00056	0.000591	CcSEcCtD
Gadoxetate—Anaphylactic shock—Timolol—glaucoma	0.000555	0.000586	CcSEcCtD
Gadoxetate—Oedema—Timolol—glaucoma	0.000555	0.000586	CcSEcCtD
Gadoxetate—ABCC4—NRF2 pathway—SLC6A1—glaucoma	0.000552	0.0107	CbGpPWpGaD
Gadoxetate—Pruritus—Clonidine—glaucoma	0.000552	0.000582	CcSEcCtD
Gadoxetate—ABCC4—Platelet degranulation—SOD1—glaucoma	0.000552	0.0107	CbGpPWpGaD
Gadoxetate—Infection—Timolol—glaucoma	0.000552	0.000582	CcSEcCtD
Gadoxetate—Shock—Timolol—glaucoma	0.000546	0.000576	CcSEcCtD
Gadoxetate—Nervous system disorder—Timolol—glaucoma	0.000544	0.000574	CcSEcCtD
Gadoxetate—Urticaria—Betaxolol—glaucoma	0.00054	0.000569	CcSEcCtD
Gadoxetate—Skin disorder—Timolol—glaucoma	0.000539	0.000569	CcSEcCtD
Gadoxetate—Body temperature increased—Betaxolol—glaucoma	0.000537	0.000567	CcSEcCtD
Gadoxetate—Hyperhidrosis—Timolol—glaucoma	0.000537	0.000566	CcSEcCtD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—PEX19—glaucoma	0.000536	0.0103	CbGpPWpGaD
Gadoxetate—Diarrhoea—Clonidine—glaucoma	0.000534	0.000563	CcSEcCtD
Gadoxetate—Anorexia—Timolol—glaucoma	0.000529	0.000558	CcSEcCtD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—SOD1—glaucoma	0.000526	0.0102	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—TXN—glaucoma	0.000523	0.0101	CbGpPWpGaD
Gadoxetate—Hypotension—Timolol—glaucoma	0.000519	0.000547	CcSEcCtD
Gadoxetate—Dizziness—Clonidine—glaucoma	0.000516	0.000544	CcSEcCtD
Gadoxetate—Hypersensitivity—Betaxolol—glaucoma	0.000501	0.000528	CcSEcCtD
Gadoxetate—Paraesthesia—Timolol—glaucoma	0.000499	0.000526	CcSEcCtD
Gadoxetate—Vomiting—Clonidine—glaucoma	0.000496	0.000523	CcSEcCtD
Gadoxetate—Dyspnoea—Timolol—glaucoma	0.000495	0.000522	CcSEcCtD
Gadoxetate—Rash—Clonidine—glaucoma	0.000492	0.000519	CcSEcCtD
Gadoxetate—Dermatitis—Clonidine—glaucoma	0.000492	0.000519	CcSEcCtD
Gadoxetate—Headache—Clonidine—glaucoma	0.000489	0.000516	CcSEcCtD
Gadoxetate—Asthenia—Betaxolol—glaucoma	0.000488	0.000514	CcSEcCtD
Gadoxetate—Decreased appetite—Timolol—glaucoma	0.000483	0.000509	CcSEcCtD
Gadoxetate—Pruritus—Betaxolol—glaucoma	0.000481	0.000507	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Timolol—glaucoma	0.000479	0.000506	CcSEcCtD
Gadoxetate—ABCC3—NRF2 pathway—TGFB2—glaucoma	0.000479	0.00924	CbGpPWpGaD
Gadoxetate—Fatigue—Timolol—glaucoma	0.000479	0.000505	CcSEcCtD
Gadoxetate—ABCC4—Ectoderm Differentiation—PAX6—glaucoma	0.000478	0.00923	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—SLC6A1—glaucoma	0.000466	0.00899	CbGpPWpGaD
Gadoxetate—Diarrhoea—Betaxolol—glaucoma	0.000465	0.00049	CcSEcCtD
Gadoxetate—Nausea—Clonidine—glaucoma	0.000464	0.000489	CcSEcCtD
Gadoxetate—Feeling abnormal—Timolol—glaucoma	0.000458	0.000483	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Timolol—glaucoma	0.000454	0.000479	CcSEcCtD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000452	0.00873	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—TGFB2—glaucoma	0.00045	0.00869	CbGpPWpGaD
Gadoxetate—Dizziness—Betaxolol—glaucoma	0.000449	0.000474	CcSEcCtD
Gadoxetate—Urticaria—Timolol—glaucoma	0.000441	0.000465	CcSEcCtD
Gadoxetate—Body temperature increased—Timolol—glaucoma	0.000439	0.000463	CcSEcCtD
Gadoxetate—Abdominal pain—Timolol—glaucoma	0.000439	0.000463	CcSEcCtD
Gadoxetate—Vomiting—Betaxolol—glaucoma	0.000432	0.000456	CcSEcCtD
Gadoxetate—Rash—Betaxolol—glaucoma	0.000429	0.000452	CcSEcCtD
Gadoxetate—Dermatitis—Betaxolol—glaucoma	0.000428	0.000452	CcSEcCtD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000427	0.00824	CbGpPWpGaD
Gadoxetate—Headache—Betaxolol—glaucoma	0.000426	0.000449	CcSEcCtD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000425	0.0082	CbGpPWpGaD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.00041	0.00792	CbGpPWpGaD
Gadoxetate—Hypersensitivity—Timolol—glaucoma	0.000409	0.000431	CcSEcCtD
Gadoxetate—Nausea—Betaxolol—glaucoma	0.000404	0.000426	CcSEcCtD
Gadoxetate—Asthenia—Timolol—glaucoma	0.000398	0.00042	CcSEcCtD
Gadoxetate—Pruritus—Timolol—glaucoma	0.000393	0.000414	CcSEcCtD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000385	0.00744	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—FN1—glaucoma	0.000384	0.00742	CbGpPWpGaD
Gadoxetate—Diarrhoea—Timolol—glaucoma	0.00038	0.000401	CcSEcCtD
Gadoxetate—ABCC2—NRF2 pathway—TGFB2—glaucoma	0.00038	0.00733	CbGpPWpGaD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000377	0.00727	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.00037	0.00714	CbGpPWpGaD
Gadoxetate—Dizziness—Timolol—glaucoma	0.000367	0.000387	CcSEcCtD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—FN1—glaucoma	0.000366	0.00707	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000362	0.00699	CbGpPWpGaD
Gadoxetate—ABCC3—Fluoropyrimidine Activity—TP53—glaucoma	0.000359	0.00693	CbGpPWpGaD
Gadoxetate—Vomiting—Timolol—glaucoma	0.000353	0.000372	CcSEcCtD
Gadoxetate—Rash—Timolol—glaucoma	0.00035	0.000369	CcSEcCtD
Gadoxetate—Dermatitis—Timolol—glaucoma	0.00035	0.000369	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—NARFL—glaucoma	0.000348	0.00672	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CA5A—glaucoma	0.000348	0.00672	CbGpPWpGaD
Gadoxetate—Headache—Timolol—glaucoma	0.000348	0.000367	CcSEcCtD
Gadoxetate—ABCC4—Fluoropyrimidine Activity—TP53—glaucoma	0.000338	0.00651	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000334	0.00644	CbGpPWpGaD
Gadoxetate—Nausea—Timolol—glaucoma	0.00033	0.000348	CcSEcCtD
Gadoxetate—ABCC3—NRF2 pathway—GSTM1—glaucoma	0.000326	0.00628	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—TGFB2—glaucoma	0.000323	0.00624	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—NARFL—glaucoma	0.000314	0.00606	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CA5A—glaucoma	0.000314	0.00606	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—GSTM1—glaucoma	0.000306	0.00591	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000306	0.0059	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000287	0.00554	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000285	0.0055	CbGpPWpGaD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000276	0.00532	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—GSTM1—glaucoma	0.000258	0.00498	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000257	0.00496	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000249	0.0048	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—SOD1—glaucoma	0.000245	0.00473	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000242	0.00466	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CA5A—glaucoma	0.000234	0.00452	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NARFL—glaucoma	0.000234	0.00452	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—VEGFA—glaucoma	0.00022	0.00424	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	0.00021	0.00404	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000209	0.00402	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000204	0.00393	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000191	0.00369	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000188	0.00363	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000177	0.00341	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—FN1—glaucoma	0.00017	0.00329	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CA1—glaucoma	0.00017	0.00328	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—TGFB2—glaucoma	0.000167	0.00322	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CTSA—glaucoma	0.000165	0.00318	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CA2—glaucoma	0.000156	0.003	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CA1—glaucoma	0.000153	0.00296	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000152	0.00293	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000152	0.00293	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000149	0.00288	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CTSA—glaucoma	0.000149	0.00287	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CA2—glaucoma	0.00014	0.00271	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.00014	0.0027	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000137	0.00265	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000137	0.00265	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—SOD1—glaucoma	0.000126	0.00244	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CA1—glaucoma	0.000114	0.00221	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CTSA—glaucoma	0.000111	0.00214	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—TXN—glaucoma	0.00011	0.00211	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CA2—glaucoma	0.000105	0.00202	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000102	0.00197	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000102	0.00197	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.0001	0.00193	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.91e-05	0.00191	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—TXN—glaucoma	9.89e-05	0.00191	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—VEGFA—glaucoma	9.76e-05	0.00188	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—MMP1—glaucoma	9.63e-05	0.00186	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—CAV1—glaucoma	9.23e-05	0.00178	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.02e-05	0.00174	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CAV1—glaucoma	8.94e-05	0.00173	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—FN1—glaucoma	8.79e-05	0.0017	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GSTT1—glaucoma	8.5e-05	0.00164	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GSTT1—glaucoma	7.67e-05	0.00148	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—TXN—glaucoma	7.36e-05	0.00142	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—NOS3—glaucoma	6.98e-05	0.00135	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.85e-05	0.00132	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP1B1—glaucoma	6.77e-05	0.00131	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ABCA1—glaucoma	6.77e-05	0.00131	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—glaucoma	6.72e-05	0.0013	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	6.66e-05	0.00128	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.18e-05	0.00119	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ABCA1—glaucoma	6.11e-05	0.00118	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP1B1—glaucoma	6.11e-05	0.00118	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTT1—glaucoma	5.71e-05	0.0011	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GSTM1—glaucoma	5.41e-05	0.00104	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—VEGFA—glaucoma	5.03e-05	0.000971	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GSTM1—glaucoma	4.88e-05	0.000942	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—MTHFR—glaucoma	4.78e-05	0.000923	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.6e-05	0.000888	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP1B1—glaucoma	4.55e-05	0.000878	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ABCA1—glaucoma	4.55e-05	0.000878	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—APOE—glaucoma	4.45e-05	0.000859	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CAV1—glaucoma	4.41e-05	0.000851	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—MTHFR—glaucoma	4.32e-05	0.000833	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—APOE—glaucoma	4.02e-05	0.000775	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CAV1—glaucoma	3.98e-05	0.000768	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—TP53—glaucoma	3.8e-05	0.000733	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTM1—glaucoma	3.64e-05	0.000702	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—NOS3—glaucoma	3.34e-05	0.000644	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—MTHFR—glaucoma	3.21e-05	0.00062	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PTGS2—glaucoma	3.05e-05	0.000589	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—NOS3—glaucoma	3.01e-05	0.000581	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—APOE—glaucoma	2.99e-05	0.000577	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CAV1—glaucoma	2.96e-05	0.000572	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PTGS2—glaucoma	2.75e-05	0.000531	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NOS3—glaucoma	2.24e-05	0.000433	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PTGS2—glaucoma	2.05e-05	0.000396	CbGpPWpGaD
